Back

UDCA May Promote COVID-19 Recovery: A Cohort Study with AI-Aided Analysis

Yu, Y.; Yu, G.; Han, L.-Y.; Li, J.; Zhang, Z.-L.; Liu, T.-S.; Li, M.-F.; Zhan, D.-C.; Tang, S.-Q.; Zhou, Z.-H.; Wang, G.-J.

2023-05-04 infectious diseases
10.1101/2023.05.02.23289410 medRxiv
Show abstract

To investigate the impact of ursodeoxycholic acid (UDCA) treatment on the clinical outcome of mild and moderate COVID-19 cases, a retrospective analysis was conducted to evaluate the efficacy of UDCA on patients diagnosed with COVID-19 during the peak of the Omicron outbreak in China. This study presents promising results, demonstrating that UDCA significantly reduced the time to Body Temperature Recovery after admission and a higher daily dose seems to be associated with a better outcome without observed safety concerns. We also introduced VirtualBody, a physiologically plausible artificial neural network model, to generate an accurate depiction of the drug concentration-time curve individually, which represented the absorption, distribution, metabolism, and excretion of UDCA in each patient. It exhibits exceptional performance in modeling the complex PK-PD profile of UDCA, characterized by its endogenous and enterohepatic cycling properties, and further validates the effectiveness of UDCA as a treatment option from the drug exposure-response perspective. Our work highlights the potential of UDCA as a novel treatment option for periodic outbreaks of COVID-19 and introduces a new paradigm for PK-PD analysis in retrospective studies to provide evidence for optimal dosing strategies.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
npj Digital Medicine
○ 118 papers in training set
Top 0.7%
7.9%
Similar papers in this journal
2
Clinical Pharmacology & Therapeutics
○ 25 papers in training set
Top 0.1%
7.9%
Similar papers in this journal
3
Cell Discovery
○ 57 papers in training set
Top 0.1%
6.8%
Similar papers in this journal
4
Frontiers in Pharmacology
○ 111 papers in training set
Top 0.2%
6.8%
Similar papers in this journal
5
eBioMedicine
○ 183 papers in training set
Top 0.3%
5.6%
Similar papers in this journal
6
Nature Communications
○ 5641 papers in training set
Top 27%
5.5%
7
Frontiers in Medicine
○ 120 papers in training set
Top 0.9%
3.3%
8
Communications Medicine
○ 113 papers in training set
Top 0.6%
3.3%
9
Scientific Reports
○ 3612 papers in training set
Top 33%
3.2%
50% of probability mass above
10
Cell Reports Medicine
○ 153 papers in training set
Top 1%
2.5%
11
Clinical and Translational Science
○ 22 papers in training set
Top 0.2%
2.4%
12
Nature Medicine
○ 125 papers in training set
Top 1%
2.1%
13
Nature Biomedical Engineering
○ 47 papers in training set
Top 0.7%
1.9%
14
eLife
● 5828 papers in training set
Top 48%
1.9%
15
iScience
○ 1154 papers in training set
Top 15%
1.9%
16
PLOS Computational Biology
● 1863 papers in training set
Top 14%
1.7%
17
Pharmaceutics
○ 24 papers in training set
Top 0.3%
1.7%
18
Clinical and Translational Medicine
○ 31 papers in training set
Top 0.3%
1.7%
19
PLOS ONE
● 5266 papers in training set
Top 47%
1.7%
20
Genomics, Proteomics & Bioinformatics
188 papers in training set
Top 1%
1.4%
21
International Journal of Antimicrobial Agents
○ 15 papers in training set
Top 0.2%
1.4%
22
Science Advances
● 1243 papers in training set
Top 23%
1.3%
23
Computers in Biology and Medicine
○ 128 papers in training set
Top 3%
1.1%
24
Med
○ 39 papers in training set
Top 0.4%
1.1%
25
Signal Transduction and Targeted Therapy
○ 30 papers in training set
Top 0.5%
1.0%
26
Drug Safety
○ 10 papers in training set
Top 0.2%
1.0%
27
Lab on a Chip
● 96 papers in training set
Top 1%
0.8%
28
Briefings in Bioinformatics
◐ 354 papers in training set
Top 7%
0.8%
29
BMC Bioinformatics
○ 457 papers in training set
Top 6%
0.6%
30
IEEE/ACM Transactions on Computational Biology and Bioinformatics
● 38 papers in training set
Top 1%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.